AXITINIB / STADA
FORM
Film-coated tablets
STRENGTH
1mg & 5mg
INDICATIONS
Axitinib/STADA is indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of prior treatment with sunitinib or a cytokine.
Important note
Treatment with Axitinib/Stada should be conducted by a physician experienced in the use of anticancer therapies.
